Thyroid News and Research RSS Feed - Thyroid News and Research

Adolescents and young adults have lower cancer survival rates compared to children

Adolescents and young adults have lower cancer survival rates compared to children

More young people of all ages are surviving cancer than ever before, but new research published today in The Lancet Oncology journal shows that adolescents and young adults have a lower chance of surviving eight relatively common types of cancer than children, according to the latest data from a long-running study of cancer survival across Europe. [More]
SUSTAIN study to test effect of high-dose selenium on recovery of cardiac surgery patients

SUSTAIN study to test effect of high-dose selenium on recovery of cardiac surgery patients

Queen's University researcher Daren Heyland is leading a study that aims to reduce the risk of complications and improves recovery of cardiac surgery patients. [More]
New portable device with hand-held probe could help reduce unnecessary thyroid cancer surgery

New portable device with hand-held probe could help reduce unnecessary thyroid cancer surgery

A team of experts from around Europe has come together to develop a portable device with a hand-held probe that will dramatically reduce invasive diagnostic and therapeutic procedures in the treatment of thyroid nodules, saving approximately €450 million Euros every year. [More]
Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress. [More]
Scientists detect blood biomarker that may help in early diagnosis of children with ASD

Scientists detect blood biomarker that may help in early diagnosis of children with ASD

Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD. [More]
New national database could help identify major influences on miscarriage

New national database could help identify major influences on miscarriage

A new national database could help relieve the misery of miscarriage for thousands of women. [More]
Nocturnal hypoxemia closely linked to diabetic microvascular complications

Nocturnal hypoxemia closely linked to diabetic microvascular complications

Examining the poorly understood link between obstructive sleep apnea (OSA) and type 2 diabetes complications, researchers identified specific measures of low blood oxygenation that are associated with impaired kidney function and diabetic nephropathy. [More]
Novel function of PLK1 gene in prostate cancer metastasis

Novel function of PLK1 gene in prostate cancer metastasis

Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1's role in cancer growth and progression. [More]
LOXO-101 drug shows efficacy with tumor regression in varied types of genetically defined cancer

LOXO-101 drug shows efficacy with tumor regression in varied types of genetically defined cancer

A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a study led by The University of Texas MD Anderson Cancer Center. [More]
International panel reclassifies a type of thyroid tumor to reduce cancer overdiagnosis

International panel reclassifies a type of thyroid tumor to reduce cancer overdiagnosis

Led by researchers at the University of Pittsburgh School of Medicine, an international panel of pathologists and clinicians has reclassified a type of thyroid cancer to reflect that it is noninvasive and has a low risk of recurrence. The name change, described today in JAMA Oncology, is expected to reduce the psychological and medical consequences of a cancer diagnosis, potentially affecting thousands of people worldwide. [More]
Coronary heart disease, cancer less likely among people with learning disabilities

Coronary heart disease, cancer less likely among people with learning disabilities

Coronary heart disease and cancer rates among people with learning disabilities are nearly a third lower than the general population, says new research. [More]
Brominated fire retardants overstimulate aldosterone in a way that may lead to cardiovascular disease

Brominated fire retardants overstimulate aldosterone in a way that may lead to cardiovascular disease

Brominated fire retardants, used in many consumer products and known to cause hormonal irregularities, overstimulates an adrenal gland hormone in a way that may lead to the development of cardiovascular disease, new research in human cells finds. Researchers will present their study results Saturday at the Endocrine Society's 98th annual meeting in Boston. [More]
Endocrine Society issues recommendations to improve care for people with diabetes

Endocrine Society issues recommendations to improve care for people with diabetes

To provide integrated care for people who have diabetes and may be at risk of developing related medical complications, the U.S. health care system needs to continue building effective multidisciplinary care team models, according to new recommendations issued by the Endocrine Society today. [More]
New ultra-sensitive technique shows promise as diagnostic tool for cancers, HIV

New ultra-sensitive technique shows promise as diagnostic tool for cancers, HIV

A common theme in medicine is that detecting a disease early on can lead to more effective treatments. This relies partly on luck that the patient gets screened at the right time, but more important is that the testing techniques are sensitive enough to register the minuscule hints that diseases leave in the blood stream. [More]
Simple method could make early disease diagnosis much easier

Simple method could make early disease diagnosis much easier

Detecting diseases such as cancer in their earliest stages can make a huge difference in patient treatment, but it is often difficult to do. Now scientists report in the journal ACS Central Science a new, simple method that could make early disease diagnosis much easier. [More]
Study reveals demographic and clinical disparities associated with substernal thyroid goiters

Study reveals demographic and clinical disparities associated with substernal thyroid goiters

Older patients, minorities, and male patients are more likely to develop substernal thyroid goiters that are difficult to remove surgically, putting them at risk for treatment complications and death, say researchers in the January 6 online in the American Journal of Surgery. [More]
New report reveals malignant brain tumors as most common cause of cancer-related deaths in young people

New report reveals malignant brain tumors as most common cause of cancer-related deaths in young people

A new report published in the journal Neuro-Oncology and funded by the American Brain Tumor Association finds that malignant brain tumors are the most common cause of cancer-related deaths in adolescents and young adults aged 15-39 and the most common cancer occurring among 15-19 year olds. [More]
SOM0226 (tolcapone) drug could significantly improve pharmacological treatment of ATTR

SOM0226 (tolcapone) drug could significantly improve pharmacological treatment of ATTR

Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR). [More]
New TAU study suggests potential therapeutic pathway to keep osteosarcoma lesions dormant

New TAU study suggests potential therapeutic pathway to keep osteosarcoma lesions dormant

Osteosarcoma is a cancer that develops in the bones of children and adolescents. It is one of the most aggressive cancers, with only a 15 per cent, five-year survival rate when diagnosed in an advanced metastatic stage. There are approximately 800 new cases diagnosed each year in the US, and no viable treatments. [More]
Proton beam therapy safe for treating childhood brain cancer medulloblastoma

Proton beam therapy safe for treating childhood brain cancer medulloblastoma

Proton beam therapy--a more precise form of radiotherapy--to treat the childhood brain cancer medulloblastoma appears to be as safe as conventional radiotherapy with similar survival rates, according to new research published in The Lancet Oncology journal today. [More]
Advertisement
Advertisement